Medicare Advantage contract
H2853 Ascension Complete
Local CCP · Parent: Centene Corporation
⚠ Non-renewal
Latest enrollment
1,343
2023-01
Year-over-year
+57.4%
contract book
National MA share
+0.0%
rank #646 of 995
Overall stars (latest)
★★★ 3.0
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2021 | — | — | — | — |
| 2022 | — | — | — | — |
| 2023 | — | — | 2.5 | — |
| 2024 | ★★★ 3.0 | 2.5 | 3.5 | — |
Premium
No premium file loaded for this contract yet.
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- D10 Medication Adherence for Cholesterol (Statins) 2★ → 4★
- D12 Statin Use in Persons with Diabetes (SUPD) 5★ → 3★
- D01 Call Center Foreign Language Interpreter and TTY Availability 3★ → 5★
- D09 Medication Adherence for Hypertension (RAS antagonists) 2★ → 3★
- D08 Medication Adherence for Diabetes Medications 1★ → 2★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →